ID   SIGL8_HUMAN             Reviewed;         499 AA.
AC   Q9NYZ4; Q7Z728;
DT   08-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   08-NOV-2002, sequence version 2.
DT   03-AUG-2022, entry version 176.
DE   RecName: Full=Sialic acid-binding Ig-like lectin 8;
DE            Short=Siglec-8;
DE   AltName: Full=Sialoadhesin family member 2;
DE            Short=SAF-2;
DE   Flags: Precursor;
GN   Name=SIGLEC8; Synonyms=SAF2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=11095983; DOI=10.1006/bbrc.2000.3866;
RA   Foussias G., Yousef G.M., Diamandis E.P.;
RT   "Molecular characterization of a siglec8 variant containing cytoplasmic
RT   tyrosine-based motifs, and mapping of the siglec8 gene.";
RL   Biochem. Biophys. Res. Commun. 278:775-781(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), TISSUE SPECIFICITY, AND FUNCTION.
RX   PubMed=10856141; DOI=10.1067/mai.2000.107127;
RA   Kikly K.K., Bochner B.S., Freeman S.D., Tan K.B., Gallagher K.T.,
RA   D'Alessio K.J., Holmes S.D., Abrahamson J.A., Erickson-Miller C.L.,
RA   Murdock P.R., Tachimoto H., Schleimer R.P., White J.R.;
RT   "Identification of SAF-2, a novel siglec expressed on eosinophils, mast
RT   cells, and basophils.";
RL   J. Allergy Clin. Immunol. 105:1093-1100(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), TISSUE SPECIFICITY, AND FUNCTION.
RC   TISSUE=Eosinophil;
RX   PubMed=10625619; DOI=10.1074/jbc.275.2.861;
RA   Floyd H., Ni J., Cornish A.L., Zeng Z., Liu D., Carter K.C., Steel J.,
RA   Crocker P.R.;
RT   "Siglec-8. A novel eosinophil-specific member of the immunoglobulin
RT   superfamily.";
RL   J. Biol. Chem. 275:861-866(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Floyd H., Zhang J.Q., Crocker P.R.;
RL   Submitted (OCT-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT PRO-170.
RC   TISSUE=Spleen;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6] {ECO:0007744|PDB:2N7A, ECO:0007744|PDB:2N7B}
RP   STRUCTURE BY NMR OF 17-155 IN COMPLEX WITH 6'-SULFO SIALYL-LEWIS X,
RP   DISULFIDE BONDS, MUTAGENESIS OF ARG-72; TYR-74; GLN-75; ARG-125; LYS-132;
RP   LYS-136 AND GLN-138, SITE, AND FUNCTION.
RX   PubMed=27357658; DOI=10.1073/pnas.1602214113;
RA   Propster J.M., Yang F., Rabbani S., Ernst B., Allain F.H., Schubert M.;
RT   "Structural basis for sulfation-dependent self-glycan recognition by the
RT   human immune-inhibitory receptor Siglec-8.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:E4170-E4179(2016).
RN   [7]
RP   VARIANT LEU-282.
RX   PubMed=21248752; DOI=10.1038/nature09639;
RA   Varela I., Tarpey P., Raine K., Huang D., Ong C.K., Stephens P., Davies H.,
RA   Jones D., Lin M.L., Teague J., Bignell G., Butler A., Cho J.,
RA   Dalgliesh G.L., Galappaththige D., Greenman C., Hardy C., Jia M.,
RA   Latimer C., Lau K.W., Marshall J., McLaren S., Menzies A., Mudie L.,
RA   Stebbings L., Largaespada D.A., Wessels L.F.A., Richard S., Kahnoski R.J.,
RA   Anema J., Tuveson D.A., Perez-Mancera P.A., Mustonen V., Fischer A.,
RA   Adams D.J., Rust A., Chan-On W., Subimerb C., Dykema K., Furge K.,
RA   Campbell P.J., Teh B.T., Stratton M.R., Futreal P.A.;
RT   "Exome sequencing identifies frequent mutation of the SWI/SNF complex gene
RT   PBRM1 in renal carcinoma.";
RL   Nature 469:539-542(2011).
CC   -!- FUNCTION: Putative adhesion molecule that mediates sialic-acid
CC       dependent binding to red blood cells (PubMed:10856141,
CC       PubMed:10625619). Preferentially binds to alpha-2,3-linked sialic acid.
CC       Also binds to alpha-2,6-linked sialic acid. The sialic acid recognition
CC       site may be masked by cis interactions with sialic acids on the same
CC       cell surface (PubMed:10625619). Recognizes simultaneously epitopes
CC       having a terminal N-acetylneuraminic acid (sialic acid) and an
CC       underlying 6-O-sulfated galactose. Preferentially binds to Gal-6-
CC       sulfated sialyl-Lewis X glycan epitopes (PubMed:27357658).
CC       {ECO:0000269|PubMed:10625619, ECO:0000269|PubMed:10856141,
CC       ECO:0000269|PubMed:27357658}.
CC   -!- INTERACTION:
CC       Q9NYZ4; P04155: TFF1; NbExp=3; IntAct=EBI-4314991, EBI-743871;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Long;
CC         IsoId=Q9NYZ4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NYZ4-2; Sequence=VSP_002559;
CC       Name=3;
CC         IsoId=Q9NYZ4-3; Sequence=VSP_002560;
CC   -!- TISSUE SPECIFICITY: Expressed specifically on red blood cells namely
CC       basophil, mast cells and eosinophils. {ECO:0000269|PubMed:10625619,
CC       ECO:0000269|PubMed:10856141}.
CC   -!- DOMAIN: Contains 1 copy of a cytoplasmic motif that is referred to as
CC       the immunoreceptor tyrosine-based inhibitor motif (ITIM). This motif is
CC       involved in modulation of cellular responses. The phosphorylated ITIM
CC       motif can bind the SH2 domain of several SH2-containing phosphatases.
CC   -!- MISCELLANEOUS: [Isoform 3]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the immunoglobulin superfamily. SIGLEC (sialic
CC       acid binding Ig-like lectin) family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=Siglec-8;
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_hum_Itlect_00146";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF287892; AAG00573.1; -; Genomic_DNA.
DR   EMBL; AF223403; AAF34702.1; -; mRNA.
DR   EMBL; AF195092; AAF27622.1; -; mRNA.
DR   EMBL; AF310234; AAK55140.1; -; mRNA.
DR   EMBL; BC053319; AAH53319.1; -; mRNA.
DR   CCDS; CCDS33086.1; -. [Q9NYZ4-1]
DR   CCDS; CCDS86797.1; -. [Q9NYZ4-2]
DR   RefSeq; NP_055257.2; NM_014442.2. [Q9NYZ4-1]
DR   RefSeq; XP_011525037.1; XM_011526735.2.
DR   PDB; 2N7A; NMR; -; A=17-155.
DR   PDB; 2N7B; NMR; -; A=17-155.
DR   PDBsum; 2N7A; -.
DR   PDBsum; 2N7B; -.
DR   AlphaFoldDB; Q9NYZ4; -.
DR   SMR; Q9NYZ4; -.
DR   BioGRID; 118057; 1.
DR   IntAct; Q9NYZ4; 1.
DR   STRING; 9606.ENSP00000321077; -.
DR   ChEMBL; CHEMBL4630877; -.
DR   UniLectin; Q9NYZ4; -.
DR   GlyConnect; 570; 14 N-Linked glycans.
DR   GlyGen; Q9NYZ4; 4 sites, 27 N-linked glycans (1 site).
DR   iPTMnet; Q9NYZ4; -.
DR   PhosphoSitePlus; Q9NYZ4; -.
DR   BioMuta; SIGLEC8; -.
DR   DMDM; 25009268; -.
DR   jPOST; Q9NYZ4; -.
DR   MassIVE; Q9NYZ4; -.
DR   PaxDb; Q9NYZ4; -.
DR   PeptideAtlas; Q9NYZ4; -.
DR   PRIDE; Q9NYZ4; -.
DR   ProteomicsDB; 83307; -. [Q9NYZ4-1]
DR   ProteomicsDB; 83308; -. [Q9NYZ4-2]
DR   ProteomicsDB; 83309; -. [Q9NYZ4-3]
DR   Antibodypedia; 2297; 317 antibodies from 33 providers.
DR   DNASU; 27181; -.
DR   Ensembl; ENST00000321424.7; ENSP00000321077.2; ENSG00000105366.15. [Q9NYZ4-1]
DR   Ensembl; ENST00000340550.5; ENSP00000339448.4; ENSG00000105366.15. [Q9NYZ4-2]
DR   GeneID; 27181; -.
DR   KEGG; hsa:27181; -.
DR   MANE-Select; ENST00000321424.7; ENSP00000321077.2; NM_014442.3; NP_055257.2.
DR   UCSC; uc002pwt.3; human. [Q9NYZ4-1]
DR   CTD; 27181; -.
DR   DisGeNET; 27181; -.
DR   GeneCards; SIGLEC8; -.
DR   HGNC; HGNC:10877; SIGLEC8.
DR   HPA; ENSG00000105366; Tissue enhanced (brain, lymphoid tissue).
DR   MIM; 605639; gene.
DR   neXtProt; NX_Q9NYZ4; -.
DR   OpenTargets; ENSG00000105366; -.
DR   PharmGKB; PA35778; -.
DR   VEuPathDB; HostDB:ENSG00000105366; -.
DR   eggNOG; ENOG502S41V; Eukaryota.
DR   GeneTree; ENSGT01040000240469; -.
DR   HOGENOM; CLU_024444_6_1_1; -.
DR   InParanoid; Q9NYZ4; -.
DR   OMA; YPPWNLT; -.
DR   OrthoDB; 324083at2759; -.
DR   PhylomeDB; Q9NYZ4; -.
DR   TreeFam; TF332441; -.
DR   PathwayCommons; Q9NYZ4; -.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   SignaLink; Q9NYZ4; -.
DR   BioGRID-ORCS; 27181; 20 hits in 1070 CRISPR screens.
DR   GeneWiki; SIGLEC8; -.
DR   GenomeRNAi; 27181; -.
DR   Pharos; Q9NYZ4; Tbio.
DR   PRO; PR:Q9NYZ4; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q9NYZ4; protein.
DR   Bgee; ENSG00000105366; Expressed in C1 segment of cervical spinal cord and 110 other tissues.
DR   ExpressionAtlas; Q9NYZ4; baseline and differential.
DR   Genevisible; Q9NYZ4; HS.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0030246; F:carbohydrate binding; TAS:ProtInc.
DR   GO; GO:0033691; F:sialic acid binding; IBA:GO_Central.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc.
DR   GO; GO:0007155; P:cell adhesion; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   Gene3D; 2.60.40.10; -; 3.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR013106; Ig_V-set.
DR   Pfam; PF07686; V-set; 1.
DR   SMART; SM00409; IG; 3.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 3.
DR   PROSITE; PS50835; IG_LIKE; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Disulfide bond;
KW   Glycoprotein; Immunoglobulin domain; Lectin; Membrane; Reference proteome;
KW   Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..16
FT                   /evidence="ECO:0000255"
FT   CHAIN           17..499
FT                   /note="Sialic acid-binding Ig-like lectin 8"
FT                   /id="PRO_0000014948"
FT   TOPO_DOM        17..363
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        364..384
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        385..499
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          40..123
FT                   /note="Ig-like V-type"
FT   DOMAIN          157..240
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          246..344
FT                   /note="Ig-like C2-type 2"
FT   REGION          410..443
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          451..470
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          478..499
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           445..450
FT                   /note="ITIM motif"
FT   MOTIF           468..473
FT                   /note="SLAM-like motif"
FT   BINDING         23
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT                   /evidence="ECO:0000269|PubMed:27357658,
FT                   ECO:0007744|PDB:2N7B"
FT   BINDING         72..75
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT                   /evidence="ECO:0000269|PubMed:27357658,
FT                   ECO:0007744|PDB:2N7B"
FT   BINDING         125
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT                   /evidence="ECO:0000269|PubMed:27357658,
FT                   ECO:0007744|PDB:2N7B"
FT   BINDING         134..138
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT                   /evidence="ECO:0000269|PubMed:27357658,
FT                   ECO:0007744|PDB:2N7B"
FT   SITE            125
FT                   /note="Indispensable role in 6'-sulfo sialyl-Lewis X"
FT                   /evidence="ECO:0000269|PubMed:27357658"
FT   CARBOHYD        172
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        249
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        267
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        42..181
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        47..107
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:27357658, ECO:0007744|PDB:2N7A,
FT                   ECO:0007744|PDB:2N7B"
FT   DISULFID        175..224
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        283..328
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         152..245
FT                   /note="ALTHRPDILILGTLESGHSRNLTCSVPWACKQGTPPMISWIGASVSSPGPTT
FT                   ARSSVLTLTPKPQDHGTSLTCQVTLPGTGVTTTSTVRLDVSY -> D (in isoform
FT                   2)"
FT                   /evidence="ECO:0000303|Ref.4"
FT                   /id="VSP_002559"
FT   VAR_SEQ         416..499
FT                   /note="GPLTESWKDGNPLKKPPPAVAPSSGEEGELHYATLSFHKVKPQDPQGQEATD
FT                   SEYSEIKIHKRETAETQACLRNHNPSSKEVRG -> VSDVGFSTPSIQPGHL (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10625619,
FT                   ECO:0000303|PubMed:10856141"
FT                   /id="VSP_002560"
FT   VARIANT         170
FT                   /note="S -> P (in dbSNP:rs10409962)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_021487"
FT   VARIANT         282
FT                   /note="V -> L (found in a renal cell carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:21248752"
FT                   /id="VAR_064751"
FT   VARIANT         388
FT                   /note="R -> G (in dbSNP:rs3829659)"
FT                   /id="VAR_049930"
FT   MUTAGEN         72
FT                   /note="R->A: Strongly impaired binding to 6'-sulfo
FT                   sialyl-Lewis X."
FT                   /evidence="ECO:0000269|PubMed:27357658"
FT   MUTAGEN         74
FT                   /note="Y->A: Modestly affected binding to 6'-sulfo
FT                   sialyl-Lewis X."
FT                   /evidence="ECO:0000269|PubMed:27357658"
FT   MUTAGEN         75
FT                   /note="Q->A: Modestly affected binding to 6'-sulfo
FT                   sialyl-Lewis X."
FT                   /evidence="ECO:0000269|PubMed:27357658"
FT   MUTAGEN         125
FT                   /note="R->A: Abolishes binding to 6'-sulfo sialyl-Lewis X."
FT                   /evidence="ECO:0000269|PubMed:27357658"
FT   MUTAGEN         132
FT                   /note="K->A: Strongly impaired binding to 6'-sulfo
FT                   sialyl-Lewis X."
FT                   /evidence="ECO:0000269|PubMed:27357658"
FT   MUTAGEN         136
FT                   /note="K->A: Strongly impaired binding to 6'-sulfo
FT                   sialyl-Lewis X."
FT                   /evidence="ECO:0000269|PubMed:27357658"
FT   MUTAGEN         138
FT                   /note="Q->A: Minor effects on binding to 6'-sulfo
FT                   sialyl-Lewis X."
FT                   /evidence="ECO:0000269|PubMed:27357658"
FT   HELIX           18..20
FT                   /evidence="ECO:0007829|PDB:2N7A"
FT   TURN            23..26
FT                   /evidence="ECO:0007829|PDB:2N7A"
FT   STRAND          28..31
FT                   /evidence="ECO:0007829|PDB:2N7A"
FT   STRAND          33..38
FT                   /evidence="ECO:0007829|PDB:2N7A"
FT   STRAND          43..45
FT                   /evidence="ECO:0007829|PDB:2N7A"
FT   STRAND          47..50
FT                   /evidence="ECO:0007829|PDB:2N7A"
FT   STRAND          62..68
FT                   /evidence="ECO:0007829|PDB:2N7A"
FT   TURN            73..75
FT                   /evidence="ECO:0007829|PDB:2N7A"
FT   STRAND          79..82
FT                   /evidence="ECO:0007829|PDB:2N7A"
FT   TURN            90..95
FT                   /evidence="ECO:0007829|PDB:2N7A"
FT   STRAND          96..98
FT                   /evidence="ECO:0007829|PDB:2N7A"
FT   HELIX           102..104
FT                   /evidence="ECO:0007829|PDB:2N7A"
FT   STRAND          109..113
FT                   /evidence="ECO:0007829|PDB:2N7A"
FT   HELIX           116..118
FT                   /evidence="ECO:0007829|PDB:2N7A"
FT   STRAND          120..128
FT                   /evidence="ECO:0007829|PDB:2N7A"
FT   STRAND          131..134
FT                   /evidence="ECO:0007829|PDB:2N7A"
FT   STRAND          146..151
FT                   /evidence="ECO:0007829|PDB:2N7A"
FT   STRAND          153..155
FT                   /evidence="ECO:0007829|PDB:2N7A"
SQ   SEQUENCE   499 AA;  54042 MW;  086EFF989B74123C CRC64;
     MLLLLLLLPL LWGTKGMEGD RQYGDGYLLQ VQELVTVQEG LCVHVPCSFS YPQDGWTDSD
     PVHGYWFRAG DRPYQDAPVA TNNPDREVQA ETQGRFQLLG DIWSNDCSLS IRDARKRDKG
     SYFFRLERGS MKWSYKSQLN YKTKQLSVFV TALTHRPDIL ILGTLESGHS RNLTCSVPWA
     CKQGTPPMIS WIGASVSSPG PTTARSSVLT LTPKPQDHGT SLTCQVTLPG TGVTTTSTVR
     LDVSYPPWNL TMTVFQGDAT ASTALGNGSS LSVLEGQSLR LVCAVNSNPP ARLSWTRGSL
     TLCPSRSSNP GLLELPRVHV RDEGEFTCRA QNAQGSQHIS LSLSLQNEGT GTSRPVSQVT
     LAAVGGAGAT ALAFLSFCII FIIVRSCRKK SARPAAGVGD TGMEDAKAIR GSASQGPLTE
     SWKDGNPLKK PPPAVAPSSG EEGELHYATL SFHKVKPQDP QGQEATDSEY SEIKIHKRET
     AETQACLRNH NPSSKEVRG
//
